Real-world-data Enabled Assessment for heaLth regulatory decision-Making

Información del proyecto

REALM

Identificador del acuerdo de subvención: 101095435

DOI

10.3030/101095435

Fecha de la firma de la CE 24 Noviembre 2022

Fecha de inicio 1 Enero 2023

Fecha de finalización 31 Diciembre 2026

Financiado con arreglo a

• Health

Coste total

€ 6 659 650,00

Aportación de la UE

€ 6 659 650,00

Coordinado por

UNIVERSITEIT MAASTRICHT
Netherlands

Periodic Reporting for period 1 - REALM (Real-world-data Enabled Assessment for heaLth regulatory decision-Making)

Período documentado: 2023-01-01 hasta 2024-06-30

Resumen del contexto y de los objetivos generales del proyecto

The REALM project addresses the growing need for a standardized, transparent, and collaborative framework for evaluating and certifying healthcare software. As medical software increasingly plays a critical role in healthcare delivery, the lack of consistent regulatory guidelines and evaluation processes poses significant challenges. REALM aims to bridge this gap by creating a regulatory sandbox environment where developers, regulatory authorities, healthcare professionals, and policy officers can collaborate. This platform will standardize tools and data resources, ensuring that healthcare software meets high-quality standards across the European Union and beyond.

The project's impact is expected to be substantial, fostering trust in digital health technologies and enabling faster, more efficient certification processes. By integrating real-world data, synthetic data, and a living lab environment, REALM will enhance the reliability and safety of medical software. The inclusion of social sciences and humanities in the project ensures that ethical considerations and human-centered approaches are integral to the software development and evaluation process, further aligning the project with EU policy priorities.

Trabajo realizado desde el comienzo del proyecto hasta el final del período abarcado por el informe y los principales resultados hasta la fecha

During the first phase of the REALM project, significant progress was made in developing the technical and scientific foundations necessary for a standardized evaluation and certification framework for healthcare software. Key activities included the comprehensive mapping and analysis of existing healthcare software regulations, which informed the design of the project’s core architecture.
The team successfully initiated the development of five critical components: Model Cards for standardized software documentation, a Federated Cloud-Based Data Resources Catalog, a Regulatory Toolbox, a Living Lab Environment, and a Post-Marketing Surveillance Module. These components collectively lay the groundwork for a robust platform that will enhance the reliability, transparency, and efficiency of healthcare software certification. Early testing and integration of these tools have already begun, marking significant technical milestones in the project.

Avances que van más allá del estado de la técnica e impacto potencial esperado (incluida la repercusión socioeconómica y las implicaciones sociales más amplias del proyecto hasta la fecha)

The REALM project has achieved significant advancements beyond the current state of the art in healthcare software evaluation. Key innovations include the development of Model Cards, which provide a standardized template for documenting software details, performance, and limitations. This innovation is crucial for ensuring transparency and consistency across the REALM platform.

Technically, the project has implemented Apache Kafka to facilitate seamless communication between the RIANA dashboard and the REALM backbone, marking a critical step in creating an integrated infrastructure. Ongoing analyses for integrating Blockchain technology are also underway, aiming to enhance data security and traceability within the platform.

These advancements position REALM as a frontrunner in setting new standards for healthcare software certification. However, to ensure widespread adoption and success, further research, market access strategies, commercialization efforts, and the development of supportive regulatory and standardization frameworks will be essential.